Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
Primary objective is to evaluate the response rates and clinical benefits of letrozole +
goserelin in premenopausal patients versus letrozole alone in postmenopausal patients with
metastatic breast cancer as first line hormonal therapy